AU616364B2 - Process for the removal of b-cyclodextrin from egg yolk or egg yolk plasma - Google Patents
Process for the removal of b-cyclodextrin from egg yolk or egg yolk plasma Download PDFInfo
- Publication number
- AU616364B2 AU616364B2 AU66973/90A AU6697390A AU616364B2 AU 616364 B2 AU616364 B2 AU 616364B2 AU 66973/90 A AU66973/90 A AU 66973/90A AU 6697390 A AU6697390 A AU 6697390A AU 616364 B2 AU616364 B2 AU 616364B2
- Authority
- AU
- Australia
- Prior art keywords
- egg yolk
- cyclodextrin
- process according
- removal
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000002969 egg yolk Anatomy 0.000 title claims abstract description 52
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 49
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 49
- 235000013345 egg yolk Nutrition 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 25
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title abstract description 7
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 32
- 239000004382 Amylase Substances 0.000 claims abstract description 15
- 102000013142 Amylases Human genes 0.000 claims abstract description 7
- 108010065511 Amylases Proteins 0.000 claims abstract description 7
- 235000019418 amylase Nutrition 0.000 claims abstract description 7
- 240000006439 Aspergillus oryzae Species 0.000 claims abstract description 6
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims abstract description 6
- 210000000496 pancreas Anatomy 0.000 claims abstract description 6
- 241000193749 Bacillus coagulans Species 0.000 claims abstract description 5
- 229940054340 bacillus coagulans Drugs 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 5
- 241000589565 Flavobacterium Species 0.000 claims abstract description 4
- 241000194105 Paenibacillus polymyxa Species 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 241000228245 Aspergillus niger Species 0.000 claims abstract description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
- 238000011534 incubation Methods 0.000 claims description 7
- 229940025131 amylases Drugs 0.000 claims description 5
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 150000001840 cholesterol esters Chemical class 0.000 claims description 3
- 229940088598 enzyme Drugs 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 1
- 108090000637 alpha-Amylases Proteins 0.000 abstract description 3
- 102000004139 alpha-Amylases Human genes 0.000 abstract 2
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 229940024171 alpha-amylase Drugs 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940097362 cyclodextrins Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000589564 Flavobacterium sp. Species 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 101150062273 fau-1 gene Proteins 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/25—Addition or treatment with microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4001611A DE4001611C1 (enExample) | 1990-01-20 | 1990-01-20 | |
| DE4001611 | 1990-01-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6697390A AU6697390A (en) | 1991-08-08 |
| AU616364B2 true AU616364B2 (en) | 1991-10-24 |
Family
ID=6398461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU66973/90A Ceased AU616364B2 (en) | 1990-01-20 | 1990-11-26 | Process for the removal of b-cyclodextrin from egg yolk or egg yolk plasma |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4980180A (enExample) |
| EP (1) | EP0439075B1 (enExample) |
| JP (1) | JP2604503B2 (enExample) |
| AT (1) | ATE95040T1 (enExample) |
| AU (1) | AU616364B2 (enExample) |
| CA (1) | CA2029916C (enExample) |
| CZ (1) | CZ279870B6 (enExample) |
| DE (2) | DE4001611C1 (enExample) |
| DK (1) | DK0439075T3 (enExample) |
| ES (1) | ES2060210T3 (enExample) |
| FI (1) | FI910278L (enExample) |
| HR (1) | HRP921065A2 (enExample) |
| HU (1) | HU212921B (enExample) |
| IE (1) | IE63669B1 (enExample) |
| MX (1) | MX172986B (enExample) |
| NO (1) | NO910208L (enExample) |
| NZ (1) | NZ236129A (enExample) |
| PL (1) | PL166697B1 (enExample) |
| RU (1) | RU2053690C1 (enExample) |
| ZA (1) | ZA909368B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU635663B2 (en) * | 1990-09-14 | 1993-03-25 | Skw Trostberg Aktiengesellschaft | Process for the production of egg yolk with reduced cholesterol content |
| AU640837B2 (en) * | 1990-12-21 | 1993-09-02 | Skw Trostberg Aktiengesellschaft | Process for the removal of cyclodextrin residues from fats and oils |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532005A (en) * | 1992-05-29 | 1996-07-02 | American Maize-Products Company | Process for removal of residual cyclodextrin |
| US5565226A (en) * | 1992-05-29 | 1996-10-15 | American Maize-Products Company | Immobilized enzyme for removal of residual cyclodextrin |
| NL9202130A (nl) * | 1992-12-09 | 1994-07-01 | Nl Ind Eiprodukten Bv | Werkwijze voor het verwijderen van Beta-cyclodextrine uit eigeel of eigeelplasma. |
| DE4331565A1 (de) * | 1993-09-16 | 1995-03-23 | Consortium Elektrochem Ind | Verfahren zur Reduktion des Gehalts an Triglyceriden im Eigelb und in eigelbhaltigen Produkten |
| US5484624A (en) * | 1995-03-31 | 1996-01-16 | Board Of Trustees Operating Michigan State University | Method for reduction of cholesterol in egg materials |
| US5738898A (en) * | 1995-03-31 | 1998-04-14 | Board Of Trustees Operating Michigan State University | Process for reducing sterols in eggs |
| US6716435B1 (en) * | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
| ATE308987T1 (de) * | 1997-04-18 | 2005-11-15 | Ganeden Biotech Inc | Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen |
| US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
| US6811786B1 (en) | 1999-04-01 | 2004-11-02 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
| US7767203B2 (en) * | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| EP1719518A1 (en) | 1998-08-07 | 2006-11-08 | Ganeden Biotech, Inc. | Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals |
| US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| US6129945A (en) * | 1998-12-10 | 2000-10-10 | Michael E. George | Methods to reduce free fatty acids and cholesterol in anhydrous animal fat |
| EP1212093B1 (en) * | 1999-08-26 | 2004-07-07 | Ganeden Biotech, Inc. | Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| US6849256B1 (en) * | 1999-11-08 | 2005-02-01 | Ganeden Biotech Incorporated | Inhibition of pathogens by probiotic bacteria |
| US20050281795A1 (en) | 2004-06-17 | 2005-12-22 | Amano Enzyme Usa., Ltd. And Amano Enzyme,Inc. | Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| EP3628164A1 (en) * | 2007-08-29 | 2020-04-01 | Ganeden Biotech, Inc. | Baked goods |
| US20090191609A1 (en) * | 2007-08-29 | 2009-07-30 | Lefkowitz Andrew R | Compositions and methods for enhancing paper product degradation |
| CA2702668C (en) * | 2007-10-16 | 2015-12-29 | Ganeden Biotech, Inc. | Beverage compositions |
| US20090305387A1 (en) * | 2008-01-30 | 2009-12-10 | Ganeden Biotech, Inc. | Compositions and methods for cleaning surfaces |
| US7788209B2 (en) * | 2008-05-05 | 2010-08-31 | United Technologies Corporation | Hybrid fault reasoning and guided troubleshooting system that uses case-based reasoning and model-based reasoning |
| US9622502B2 (en) | 2008-10-16 | 2017-04-18 | Ganeden Biotech, Inc. | Probiotic Bacillus pasta compositions |
| CA2760325A1 (en) | 2009-04-29 | 2010-11-04 | Ganeden Biotech, Inc. | Dead bacillus coagulans bacteria and uses thereof for boosting the immune system |
| US9301982B2 (en) | 2010-04-14 | 2016-04-05 | Ganeden Biotech, Inc. | Probiotic confection and lipid compositions |
| CN102578360A (zh) * | 2011-01-06 | 2012-07-18 | 盐城市方圆食品有限公司 | 一种高水解低胆固醇鸡蛋蛋白质氨基酸液的制备方法 |
| WO2012135499A1 (en) | 2011-03-31 | 2012-10-04 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
| CN103966288A (zh) * | 2013-01-30 | 2014-08-06 | 大连海洋大学 | 一种海带内生多粘芽孢杆菌抗肿瘤蛋白的制备方法及其应用 |
| CN103966287A (zh) * | 2013-01-30 | 2014-08-06 | 大连海洋大学 | 一种海洋地衣芽孢杆菌抗肿瘤蛋白的制备方法及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2844989A (en) * | 1988-01-22 | 1989-07-27 | Asterol International | Process for the elimination of steroid compounds contained in a substance of biological origin |
| AU5511290A (en) * | 1989-05-19 | 1990-11-22 | Commonwealth Scientific And Industrial Research Organisation | Cholesterol removal from eggs, dairy products and other aqueous emulsions |
| AU6083690A (en) * | 1989-08-26 | 1991-04-18 | Skw Trostberg Aktiengesellschaft | Process for the removal of cholesterol or cholesterol esters from egg yolk |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1870269A (en) * | 1930-08-16 | 1932-08-09 | Frosted Foods Co Inc | Egg product and method of producing the same |
| US3260606A (en) * | 1964-04-29 | 1966-07-12 | Taiyo Food Co Ltd | Enzymatic treatment of egg |
| US3598613A (en) * | 1968-12-19 | 1971-08-10 | Ralston Purina Co | Process for manufacturing cooked egg yolk products |
| US3510315A (en) * | 1969-02-10 | 1970-05-05 | Ralston Purina Co | Egg product |
| GB8414272D0 (en) * | 1984-06-05 | 1984-07-11 | Cpc International Inc | Enzymatic hydrolysis |
| FR2601959B1 (fr) * | 1986-07-24 | 1988-12-02 | Monserbio Gie | Procede d'elimination du cholesterol contenu dans une matiere grasse d'origine animale et matiere grasse appauvrie en cholesterol obtenue |
-
1990
- 1990-01-20 DE DE4001611A patent/DE4001611C1/de not_active Expired - Lifetime
- 1990-03-12 US US07/491,780 patent/US4980180A/en not_active Expired - Lifetime
- 1990-11-14 CA CA002029916A patent/CA2029916C/en not_active Expired - Fee Related
- 1990-11-16 IE IE414390A patent/IE63669B1/en not_active IP Right Cessation
- 1990-11-19 NZ NZ236129A patent/NZ236129A/en unknown
- 1990-11-22 ZA ZA909368A patent/ZA909368B/xx unknown
- 1990-11-26 AU AU66973/90A patent/AU616364B2/en not_active Ceased
-
1991
- 1991-01-08 HU HU9137A patent/HU212921B/hu not_active IP Right Cessation
- 1991-01-16 JP JP3003300A patent/JP2604503B2/ja not_active Expired - Lifetime
- 1991-01-17 MX MX024173A patent/MX172986B/es unknown
- 1991-01-18 AT AT91100606T patent/ATE95040T1/de not_active IP Right Cessation
- 1991-01-18 DE DE91100606T patent/DE59100408D1/de not_active Expired - Fee Related
- 1991-01-18 RU SU914894264A patent/RU2053690C1/ru active
- 1991-01-18 PL PL91288756A patent/PL166697B1/pl unknown
- 1991-01-18 ES ES91100606T patent/ES2060210T3/es not_active Expired - Lifetime
- 1991-01-18 FI FI910278A patent/FI910278L/fi not_active Application Discontinuation
- 1991-01-18 EP EP91100606A patent/EP0439075B1/de not_active Expired - Lifetime
- 1991-01-18 DK DK91100606.2T patent/DK0439075T3/da active
- 1991-01-18 NO NO91910208A patent/NO910208L/no unknown
- 1991-01-21 CZ CS91127A patent/CZ279870B6/cs unknown
-
1992
- 1992-10-16 HR HR921065A patent/HRP921065A2/hr not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2844989A (en) * | 1988-01-22 | 1989-07-27 | Asterol International | Process for the elimination of steroid compounds contained in a substance of biological origin |
| AU5511290A (en) * | 1989-05-19 | 1990-11-22 | Commonwealth Scientific And Industrial Research Organisation | Cholesterol removal from eggs, dairy products and other aqueous emulsions |
| AU6083690A (en) * | 1989-08-26 | 1991-04-18 | Skw Trostberg Aktiengesellschaft | Process for the removal of cholesterol or cholesterol esters from egg yolk |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU635663B2 (en) * | 1990-09-14 | 1993-03-25 | Skw Trostberg Aktiengesellschaft | Process for the production of egg yolk with reduced cholesterol content |
| AU640837B2 (en) * | 1990-12-21 | 1993-09-02 | Skw Trostberg Aktiengesellschaft | Process for the removal of cyclodextrin residues from fats and oils |
Also Published As
| Publication number | Publication date |
|---|---|
| IE904143A1 (en) | 1991-07-31 |
| DE4001611C1 (enExample) | 1991-02-28 |
| NO910208D0 (no) | 1991-01-18 |
| DE59100408D1 (de) | 1993-11-04 |
| EP0439075B1 (de) | 1993-09-29 |
| US4980180A (en) | 1990-12-25 |
| ZA909368B (en) | 1991-10-30 |
| HU212921B (en) | 1996-12-30 |
| CZ279870B6 (cs) | 1995-07-12 |
| JPH04341161A (ja) | 1992-11-27 |
| FI910278A7 (fi) | 1991-07-21 |
| ATE95040T1 (de) | 1993-10-15 |
| HU910037D0 (en) | 1991-08-28 |
| NO910208L (no) | 1991-07-22 |
| FI910278L (fi) | 1991-07-21 |
| JP2604503B2 (ja) | 1997-04-30 |
| CA2029916C (en) | 1995-09-12 |
| HRP921065A2 (en) | 1995-04-30 |
| IE63669B1 (en) | 1995-05-31 |
| DK0439075T3 (da) | 1993-11-08 |
| NZ236129A (en) | 1992-04-28 |
| HUT61332A (en) | 1992-12-28 |
| EP0439075A1 (de) | 1991-07-31 |
| RU2053690C1 (ru) | 1996-02-10 |
| CS9100127A2 (en) | 1991-08-13 |
| CA2029916A1 (en) | 1991-07-21 |
| PL166697B1 (pl) | 1995-06-30 |
| ES2060210T3 (es) | 1994-11-16 |
| FI910278A0 (fi) | 1991-01-18 |
| MX172986B (es) | 1994-01-26 |
| AU6697390A (en) | 1991-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU616364B2 (en) | Process for the removal of b-cyclodextrin from egg yolk or egg yolk plasma | |
| AU635663B2 (en) | Process for the production of egg yolk with reduced cholesterol content | |
| US5532005A (en) | Process for removal of residual cyclodextrin | |
| IE65633B1 (en) | Process for the removal of cyclodextrin residues from fats and oils | |
| US5565226A (en) | Immobilized enzyme for removal of residual cyclodextrin | |
| AU684990C (en) | Immobilized enzyme for removal of residual cyclodextrin | |
| MXPA96006577A (es) | Enzima inmovilizada para la eliminacion de ciclodextrina residual |